Neuroblastoma trials in Brazil

2 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

• Phase 1/2Taking people
  Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

  Where

  Barretos, Curitiba, Porto Alegre, São José do Rio Preto

  Age

  6 months to 25 years

  People

  90 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT06395103 · EU 2023-507178-41-00
• Phase 2Taking people
  Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma

  Where

  São Paulo

  Age

  12 months to 21 years

  People

  93 worldwide

  Run by

  Giselle Sholler

  See details and how to joinNCT05489887 · EU 2025-524140-35-00